Post-traumatic pseudoaneurysm of the common hepatic artery with duodenal fistula.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 2020554)

Published in HPB (Oxford) on January 01, 2002


Gabriel E Gondolesi1, Cal Matsumoto, Michael Wayne, Myron E Schwartz

Author Affiliations

1: The RecanatilMiller Transplantation Institute, Mount Sinai Hospital, New York, NY 10029, USA.

Articles by these authors

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93

Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology (2011) 2.66

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl (2010) 2.57

Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg (2002) 2.14

A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology (2009) 1.90

Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl (2004) 1.88

Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg (2012) 1.70

Biliary complications in 96 consecutive right lobe living donor transplant recipients. Transplantation (2004) 1.57

Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50

Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol (2007) 1.49

Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int (2010) 1.46

Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44

Extremely high body mass index is not a contraindication to laparoscopic gastric bypass. Obes Surg (2004) 1.43

Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36

Anatomic variations in right liver living donors. J Am Coll Surg (2004) 1.33

Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response. Cancer (2009) 1.28

Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol (2008) 1.26

Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transplant (2004) 1.17

Quality of life after lobectomy for adult liver transplantation. Transplantation (2002) 1.15

Perioperative blood transfusion and long-term outcomes after resection of hilar cholangiocarcinoma. J Gastrointest Surg (2015) 1.07

Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery (2007) 1.07

Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobiliary Pancreat Surg (2002) 1.03

Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg (2008) 1.02

Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Ann Surg (2014) 0.99

Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg (2002) 0.94

Preoperative evaluation and a risk assessment in patients undergoing abdominal surgery. Surg Today (2010) 0.92

Resection of large hepatocellular carcinoma (≥10 cm): a unique western perspective. J Surg Oncol (2012) 0.90

Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation. Hepatology (2015) 0.88

Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol (2008) 0.86

Giant hemangioma of the adrenal. Isr Med Assoc J (2004) 0.85

Actual 10-year survival following hepatectomy for hepatocellular carcinoma. HPB (Oxford) (2013) 0.84

Invasive colloid carcinoma arising from intraductal papillary neoplasm in a 50-year-old woman with primary sclerosing cholangitis. Semin Liver Dis (2004) 0.84

Hemodynamic changes during laparoscopic gastric bypass procedures. Arch Surg (2005) 0.83

Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications. Surgery (2013) 0.83

Three synchronous, sporadic and separate periampullary and pancreatic tumors: more than a coincidence? World J Surg Oncol (2014) 0.83

Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation (2005) 0.83

Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl (2005) 0.82

Surgical treatment of intrahepatic cholangiocarcinoma in the USA. J Hepatobiliary Pancreat Sci (2014) 0.82

Results of retransplantation for recurrent hepatitis C. Hepatology (2003) 0.82

An integrated approach to intestinal failure: results of a new program with total parenteral nutrition, bowel rehabilitation, and transplantation. J Gastrointest Surg (2002) 0.82

Outcomes following resection of intrahepatic cholangiocarcinoma. HPB (Oxford) (2014) 0.81

Diaphragmatic hernia after hepatic resection: case series at a single Western institution. J Gastrointest Surg (2012) 0.81

The role of fibrin sealants in hepatic surgery. Surg Technol Int (2007) 0.81

Pregnancy in an intestinal transplant recipient. Obstet Gynecol (2012) 0.79

Liver allograft outcomes after laparoscopic-assisted and minimal access live donor hepatectomy for transplantation. Am J Surg (2011) 0.79

Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors. Neuroendocrinology (2015) 0.79

Liver transplantation for liver rupture due to light chain deposition disease: a case report. Semin Liver Dis (2006) 0.78

Robotic pancreatic surgery is no substitute for experience and clinical judgment: an initial experience and literature review. World J Surg Oncol (2013) 0.78

Surgical resection for advanced gallbladder carcinoma. The Mount Sinai experience. Hepatogastroenterology (2011) 0.78

Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis. J Am Coll Surg (2003) 0.78

Syngeneic living-donor liver transplantation without the use of immunosuppression. Gastroenterology (2002) 0.77

Advancing the diagnosis and treatment of hepatocellular carcinoma. Liver Transpl (2005) 0.77

Use of robotics during laparoscopic gastric bypass for morbid obesity. JSLS (2005) 0.77

Functional abdominal complaints occurred frequently in living liver donors after donation. Scand J Gastroenterol (2010) 0.76

Venous hemodynamics in living donor right lobe liver transplantation. Liver Transpl (2002) 0.76

Surgical management of hepatocellular carcinoma. Mt Sinai J Med (2012) 0.76

Voriconazole-associated myositis. J Clin Rheumatol (2009) 0.76

Recurrent giant hemangiomas of liver: Report of two rare cases with literature review. World J Gastrointest Surg (2012) 0.75

Expansion of criteria for transplanting patients with hepatocellular carcinoma. Liver Transpl (2008) 0.75

Biliary pain, no gallstones--remove the gallbladder, anyway? J Fam Pract (2014) 0.75

Laparoscopic splenectomy combined with revision of previous laparoscopic gastric bypass. Obes Surg (2004) 0.75

Sudden liver failure. Am J Med (2006) 0.75